Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Rheumatology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Rheumatology Other
    Rilonacept Approved in the EU for Cryopyrin-Associated Periodic Syndromes - (DGNews)
    Canakinumab Gives Faster, Greater Pain Relief in Refractory Gout Patients: Presented at ACR/ARHP - (DGDispatch)
    Previous Urate-Lowering Therapy Plus Febuxostat Lowers Urate Levels, Number of Flares in Patients With Gout: Presented at ACR/ARHP - (DGDispatch)
    Low-Dose Colchicine Eases Pain Due to Acute Gout Flare: Presented at ACR/ARHP - (DGDispatch)
    Combination Therapy With Zoledronic Acid/Teriparatide Has Beneficial Effects on Bone Mass Density: Presented at ACR/ARHP - (DGDispatch)

    News archive

     Recent webcasts/CME - Rheumatology Other
    Biologics and Infections: Common and Rare

    Webcasts/CME archive

     Recent cases - Rheumatology Other
      Rectal Mucosal Prolapse Syndrome as an Unusual Gastrointestinal Manifestation of Sjogren's Syndrome: A Case Report
      HELLP Syndrome, Multiple Liver Infarctions, and Intrauterine Fetal Death in a Patient with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
      Nasal Septal Perforation in a Patient with Takayasu's Arteritis; a Rare Association
      Nummular Keratopathy in a Patient with Hyper-IgD Syndrome
      Congenital Heart Block Associated with Sjogren Syndrome: Case Report

      Cases archive
        




      my personal edition > rheumatology other > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Steroid Effect Temporary In Carpal Tunnel Syndrome

      A DGReview of :"Comparison of open carpal tunnel release and local steroid treatment outcomes in idiopathic carpal tunnel syndrome"
      Rheumatology International

      05/28/2002
      By Anne MacLennan


      Steroid injection for carpal tunnel syndrome is as good as surgical release of the median nerve at three months, but is not long-lasting, researchers in Turkey have found.

      This comparison of local steroid injection versus open carpal tunnel release was by Serpil Demirci and colleagues from Suleyman Demirel University School of Medicine, Isparta, and Hosdere Caddes, Ankara.

      Ninety patients with electrophysiologically proven idiopathic carpal tunnel syndrome participated in this study. Forty-four were treated surgically, 46 were treated with a two-dose steroid injection.

      A symptom and function status questionnaire (Boston Questionnaire) and sensory and motor nerves conduction studies was used to compare the groups. The electrophysiological studies and questionnaire were applied before and at the third and sixth month after treatment.

      Both groups showed significant improvement at the first follow-up at three months.

      However, between the third- and sixth-month evaluations, the surgically treated group showed significant and further improvement of symptoms and conduction values, whereas no significant changes were seen in those treated by steroid injection.

      By the end of follow-up, 5 percent of the hands in the open carpal tunnel release group and 13 percent of those in the local steroid injection group showed electrophysiological worsening. At the same time, there was symptomatic worsening in 5 percent of hands in the surgical group versus 22 percent of hands in steroid injection group.

      The authors conclude that while steroid injection provides an improvement comparable with that from surgical release at three months post-treatment, this improvement is not does not last long.
      Rheumatol Int (2002) 22: 33-37. "Comparison of open carpal tunnel release and local steroid treatment outcomes in idiopathic carpal tunnel syndrome"

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send